Floatz logo

Anti-Mesothelin Car Nk Cells

Epithelial Ovarian Cancer

Allife Medical Science and Technology Co., Ltd.Cell therapyEarly Phase 1Dormant
C
36/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
73/ 100

Competitive context

245 Active assets in the Epithelial Ovarian Cancer cohort.

Asset / SponsorPhaseRating
Trabectedin
AGO Research GmbH
Phase 4BBB
Mirvetuximab Soravtansine
AstraZeneca
Phase 3BBB
Olaparib
Imunon
Phase 4BB
Irinotecan
OHSU Knight Cancer Institute
Phase 2BB
Carboplatin
University of Washington
Phase 3BB

View all 50 →

Same molecule, other indications

Anti-Mesothelin Car Nk Cells is also rated in:

Stage IV Ovarian CancerDormant
CC
Indicative ·
43 / 100
View asset →
Testis Cancer, RefractoryDormant
CC
Indicative ·
43 / 100
View asset →
Endometrial Cancer RecurrentDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →